Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03969654 · ClinicalTrials.gov registry record · NA
ROSA Robot Used in Total Knee Replacement Post Market Study
A NA study of Rheumatoid Arthritis and Knee Pain, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 181
- Enrollment target
- 5
- Study locations
NCT03969654 is a NA study of Rheumatoid Arthritis and Knee Pain that has completed, run by Zimmer Biomet. The registered enrollment target is 181 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT03969654, a NA study of Rheumatoid Arthritis and Knee Pain, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 181 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a prospective, multicenter clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona, NexGen, and Vanguard product families using the ROSA Total Knee Robotic System or conventional instrumentation. The primary objective of this study is to collect and compare clinical and surgical data using the commercially available ROSA Total Knee robotic instrumentation and conventional instrumentation.
Conditions Studied
Interventions
- DEVICE PERSONA Total Knee
- DEVICE Vanguard Total Knee
- DEVICE NexGen Total Knee
Study Locations (5)
Colorado
- Vail-Summit Orthopaedics - Vail
- Cornerstone Orthopedics & Sports Medicine, a division of Orthopedic Centers of Colorado, LLC - Westminster
Illinois
- SIU School of Medicine - Springfield
Michigan
- Henry Ford Health System - Detroit
Virginia
- OrthoVirginia Chippenham - North Chesterfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2023-09-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03969654
The ClinicalTrials.gov registry entry for NCT03969654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 3 interventions - of which PERSONA Total Knee is the first listed.
NCT03969654 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Colorado, Illinois, Michigan.
Frequently Asked Questions
What is clinical trial NCT03969654 about?
NCT03969654 is a clinical study titled "ROSA Robot Used in Total Knee Replacement Post Market Study". This is a prospective, multicenter clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona, NexGen, and Vanguard product families using the ROSA Total Knee Robotic System o...
What is the current status of trial NCT03969654?
This trial is currently completed. It is a NA study. The enrollment target is 181 participants. The study started on 2020-05-01. Estimated completion is 2023-09-22.
What conditions does trial NCT03969654 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Knee Pain, Moderate Varus, Valgus or Flexion Deformities, Avascular Necrosis of the Femoral Condyle, Chronic Osteoarthritis.
What interventions are being tested in trial NCT03969654?
The interventions under investigation include: PERSONA Total Knee (DEVICE), Vanguard Total Knee (DEVICE), NexGen Total Knee (DEVICE).
Who is sponsoring clinical trial NCT03969654?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03969654 being conducted?
This trial has 5 study locations across Colorado, Illinois, Michigan, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.